Weihua Liu
- Developmental Neuroscience top 5%
-
- Anesthesia and Sedative Agents 4
- Pharmacology top 5%
- Berberine and alkaloids research 6
- Nephrology top 5%
- Acute Kidney Injury Research 3
- Pharmacology top 5%
- Berberine and alkaloids research 6
-
- Sphingolipid Metabolism and Signaling 5
-
- Cancer-related molecular mechanisms research 4
-
- Neuroscience and Neuropharmacology Research 4
-
- Glioma Diagnosis and Treatment 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Co-authors
- Peiqing LiuMarkus W. HollmannChristian W. HoenemannMarcel E. DurieuxHeqing HuangXiaoyan ShenHongtao LiuTian Lan
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Weihua Liu
101 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 142
- Developmental Neuroscience 101
- Anesthesiology and Pain Medicine 135
- Pharmacology 353
- Nephrology 139
- Pharmacology 153
Countries citing papers authored by Weihua Liu
This map shows the geographic impact of Weihua Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Liu more than expected).
Fields of papers citing papers by Weihua Liu
This network shows the impact of papers produced by Weihua Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Liu. The network helps show where Weihua Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weihua Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 19 | |
| 12 | 2020 | 7 | |
| 13 | 2019 | 60 | |
| 14 | 2015 | 46 | |
| 15 | 2014 | 1 | |
| 16 | 2010 | 2 | |
| 17 | 2008 | 99 | |
| 18 | 2006 | 67 | |
| 19 | 2005 | 12 | |
| 20 | 2001 | 141 |
About Weihua Liu
Weihua Liu is a scholar working on Nephrology, Biochemistry and Biological Psychiatry, having authored 107 papers that have together received 2.5k indexed citations. Recurring topics across this work include Berberine and alkaloids research (6 papers), Sphingolipid Metabolism and Signaling (5 papers), Anesthesia and Sedative Agents (4 papers), Cancer-related molecular mechanisms research (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Glioma Diagnosis and Treatment (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Acute Kidney Injury Research (3 papers). The work is most often cited by research in Developmental Neuroscience (101 citations), Anesthesiology and Pain Medicine (135 citations) and Pharmacology (353 citations). Weihua Liu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Peiqing Liu, Markus W. Hollmann, Christian W. Hoenemann, Marcel E. Durieux, Heqing Huang, Xiaoyan Shen, Hongtao Liu, Tian Lan, Suowen Xu and Heqing Huang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.